We have studied the transcription of the CTP:phosphocholine cytidylyltransferase ␣ (CT␣) gene in C3H10T1/2 fibroblasts as a function of the cell cycle. The cells were incubated for 48 h with 0.5% fetal bovine serum. The cells were induced into the G 1 phase of the cell cycle by the addition of medium with 10% fetal bovine serum. The cells began the synthesis of DNA after 12 h. At 16 and 20 h there was an increased amount of CT␣ mRNA that coincided with an increase in the expression of CT␣ proximal promoter-luciferase constructs (؊201/؉38 and ؊130/؉38). Luciferase constructs with the basal promoter (؊52/؉38) showed no change in activity during the cell cycle. Incorporation of [ 3 H]choline into phosphatidylcholine began to increase by 8 h after the addition of serum and peaked at 18 h. The mass of phosphatidylcholine nearly doubled between 8 and 26 h after addition of serum. CT activity increased by 6 h after serum addition and was maintained until 22 h. Thus, the increase of phosphatidylcholine biosynthesis in the G 1 phase of the cell cycle is not due to enhanced transcription of the CT␣ gene. Instead increased transcription of the CT␣ gene occurred during the S phase of the cell cycle in preparation for mitosis.
CT␤2, have been identified that are encoded by a second gene (12, 13) .
While the primary mechanism by which CT activity is regulated in cells is activation by lipids after translocation to cellular membranes (1, 8, 14, 15) , it is now recognized that PC synthesis can also be regulated by changes in CT mRNA turnover and by CT gene transcription. Several reports indicate that CT can be regulated post-transcriptionally, apparently by reducing the rate of mRNA degradation (16, 17) . However, the precise mechanisms involved in regulating CT mRNA stability still have to be elucidated. Tessner et al. (16) provided the first evidence for increased CT mRNA during growth factor-stimulated PC synthesis in a murine macrophage cell line. Houweling et al. (18) demonstrated that CT is regulated at the level of its mRNA in rat liver after partial hepatectomy. The maximal increase in the CT mRNA coincided with maximal DNA synthesis 24 h after partial hepatectomy (19) . CT is highly expressed during the perinatal period and the expression of CT is positively associated with hepatic cell division (20, 21) . Tang et al. (22) isolated and characterized the murine CT␣ gene and demonstrated that the exon/intron organization of the gene corresponded to enzyme functional domains and the gene possessed two transcriptional start sites.
Our laboratory has begun studies on the transcriptional regulation of the CT␣ gene. Bakovic et al. (23) isolated the CT␣ promoter and characterized its regulatory elements and associated factors. The CT␣ promoter lacks a TAT(A/C)AAT box but contains GC-rich regions. The 5Ј-terminal ϳ200 bp of the proximal promoter contains four consensus elements for nuclear factor Ap1, overlapping sites for NFB, E2F, and Elk-1, one sterol response element (24, 25) , and 3 regulatory GC regions having Sp1-related motifs: a "loose" Sp1 site at Ϫ31/Ϫ9, a cluster of three overlapping Sp1 sites (Ϫ88/Ϫ50), and a canonical Sp1-binding site (Ϫ148/Ϫ128). These three Sp1-binding regions have basal, activator, and suppressor promoter activity, respectively (23) . Moreover, Sp1, Sp2, and Sp3 can competitively bind to these regions and the relative abundance of these factors dictates overall promoter activity of the CT␣ gene (26) . More recently we have shown that transcriptional enhancer factor 4 may stimulate the expression of the CT␣ gene (27) . Lagace et al. (24) have shown that the sterol response element-binding protein stimulates PC biosynthesis indirectly but does not appear to alter transcription of the CT␣ gene via the sterol response element. In contrast, Kast et al. (25) reported a functional sterol response element 156 bp upstream of the transcription start site. They reported induction of CT␣ mRNA and reporter constructs when Chinese hamster ovary cells or THP-1-derived macrophages were cultured in lipoprotein-deficient serum for 24 h. The induction of CT mRNA agrees with results from Ryan et al. (28) who showed that lipoprotein-deficient serum induces CT␣ mRNA and protein in an alveolar type II epithelial cell line (MLE-12).
Whether or not transcriptional regulation of the CT␣ gene occurs as a consequence of cell division has not been previously investigated. Phospholipid biosynthesis is an important aspect of the cell cycle due to the doubling of PC mass prior to mitosis. PC biosynthesis also increases when quiescent cells are triggered to enter the cell cycle by different types of stimuli (16, 29, 30, 32) . Stimulated PC synthesis was attributed to an increase in either choline kinase activity (29) or in the activity and expression of CT occurring in the first hours after stimulation (16, 18) .
Earlier studies suggested that a net increase in membrane phospholipid formation may occur sometime after the cells have exited G 1 when stimulated with either platelet-derived growth factor (33) or concanavalin A ϩ interleukin-2 (34). These two studies, however, were not designed to explore the rate of phospholipid synthesis. Jackowski (35) demonstrated in a macrophage cell line that PC accumulated during the S phase of the cell cycle, while total CT activity was maximal during G 1 . In fact, both biosynthesis and catabolism were occurring simultaneously in G 1 , but subsequently PC degradation was attenuated during S phase leading to a net increase in PC mass (35) .
Evidence from our (36) and another laboratory (37) implicates membrane PC content as an important factor in cell cycle progression through G 1 and S phase. Decreased PC synthesis and mass and cell growth arrest in G 1 occurs in C3H/10T1/2 fibroblasts, W1-38 fibroblasts, and L6 myoblasts deprived of choline. Choline addition (or lyso-PC, which can rapidly form PC) restored PC content and allowed these cells to progress into S phase. Delipidated serum by itself did not effectively restore cell cycling (36) . Thus, serum growth factors cannot substitute for choline in cell cycle re-establishment subsequent to choline deprivation. Therefore, PC has an essential role in cell division. In addition, the finding that choline addition during G 1 permits normal entry into S phase suggests a PC requirement late in G 1 (36) . The present study demonstrates for the first time that the transcription of the CT␣ gene is enhanced during the S phase of the cell cycle.
EXPERIMENTAL PROCEDURES
Cell Culture, Generation of Stable Cell Lines, and Luciferase Assays-C3H10T1/2 mouse embryo fibroblasts, clone 8 (38) were provided by Dr. W. J. Vaartjes, Utrecht, The Netherlands. These cells are highly sensitive to post-confluence inhibition of division and can be synchronized in G 0 phase by serum deprivation. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with penicillin G (100 units/ml), streptomycin (100 g/ml), and 10% fetal bovine serum (FBS) in a 5% CO 2 humidified incubator at 37°C. Subconfluent cells were passaged every 3-4 days.
Luciferase reporter plasmids containing serial deletions at the 5Ј-end of the murine CT␣ gene, LUC.C8 (Ϫ201/ϩ38), LUC.D1 (Ϫ90/ϩ38), LUC.D2 (Ϫ130/ϩ38), and LUC.D3 (Ϫ52/ϩ38) have been described (23) . Cells grown in T75 flasks at 20 -30% confluence were co-transfected with the respective CT␣ promoter-luciferase vector and the pRCMV vector (empty vector with a neomycin resistance cassette) at a 20:1 ratio by the calcium phosphate method (39) . The calcium phosphate-DNA precipitates were left on the cells for 48 h prior to splitting the cells into two 100-mm dishes. The cells were then exposed to 1 mg/ml gentamycin (Life Technologies, Inc.). Medium was changed 2-3 times per week. Individual colonies were harvested by typsinization 14 -21 days after selection and maintained in the above medium with gentamycin (0.5 mg/ml). Pools of at least 10 -15 individual colonies for each construct were screened for stable incorporation of the CT␣ promoter using luciferase activity assays. Luciferase assays were performed using the Promega assay system, as recommended by the manufacturer and a Lumat L99501 luminometer. Luciferase activity was normalized to the protein content and/or cell number. At least two stable cell lines from each pool containing different length promoter-reporter constructs were chosen for testing luciferase expression during the cell cycle by using the same methodology. The change in promoter activity during different stages of the cell cycle was expressed relative to luciferase expression in quiescent cells or G 0 stage of the cell cycle.
Serum Deprivation, Cell Cycle Induction, and Analysis of Cell Cycle
Parameters-Cell lines that contained various length promoter-reporter constructs and wild-type C3H10T1/2 cells were plated at a density of ϳ2.4 ϫ 10 3 cells/cm 2 and grown for 12 h in DMEM with 10% FBS. To synchronize cells in G 0 phase of the cell cycle, the cells were maintained for 48 h in a serum-deficient medium (0.5% FBS). The cell cycle was initiated by changing the quiescent cells to DMEM containing normal serum, 10% FBS. The control set for each analysis described was maintained on the serum-deficient medium. Each 1-2 h after serum addition, cells were collected in duplicate for measuring luciferase activity and other cell cycle parameters. Separate duplicate/triplicate experiments were performed for examining different cell cycle parameters such as thymidine incorporation, luciferase assays, CT activity, and mRNA analysis.
Fluorescent-activated Cell Sorter Analysis-To define the fraction of cells in different stages of cell growth after serum addition, the synchronized cells were washed with PBS, collected at different time points by trypsinization, fixed in 70% ethanol, and stored at Ϫ20°C. Fluorescent-activated cell sorter analysis was performed at wavelengths between 610 and 630 nm using propidium iodide as a marker for DNA.
[ 3 H]Thymidine Incorporation into DNA-For the analysis of DNA synthetic rates, [ 3 H]thymidine (0.5 Ci, 1 M) was added to triplicate 35-mm dishes 1 h before cells were harvested. At each time point, the medium was aspirated and the cells were washed three times with ice-cold PBS and treated with 10% ice-cold trichloroacetic acid for 10 min on ice to precipitate DNA. The dishes were washed twice with 10% trichloroacetic acid and the precipitated material was scraped into 0.2% SDS in 0.1 N NaOH. Radioactivity associated with the trichloroacetic acid precipitate was measured by liquid scintillation spectrometry.
Total mRNA Isolation and RT-PCR-Cells grown to different stages of the cell cycle were collected from duplicate 150-mm dishes and total mRNA was isolated by using the TRIZOL reagent (Life Technologies, Inc.). 3 g of total RNA was reverse transcribed using Superscript II reverse transcriptase (Life Technologies, Inc.) and subjected to 30 cycles of PCR amplification (95°C for 1 min, 45°C for 1 min, and 72°C for 2 min). The CT␣ specific primers used were 5Ј-ATGCACAGTGTTCAGC-CAA-3Ј (forward) and 5Ј-GGGCTTACTAAAGTCAACTTCAA-3Ј (reverse) and they produce an ϳ200-bp CT␣ fragment. Cyclophilin primers 5Ј-TCTTCTTGCTGGTCTTGCCATTCC-3Ј (forward) and 5Ј-TCCAAA-GACAGCAGAAAACTT-3Ј (reverse) were used to generate a 308-bp product to serve as a RT-PCR control (PCR conditions: 33 cycles at 94°C for 1 min, 60°C for 2 min, 72°C for 2 min).
Immunoblot Analysis-Proteins from cell lysates collected during different stages of the cell cycle (20 g of protein/lane) were resolved by electrophoresis on SDS-(8 or 10%) polyacrylamide gels and transferred to nitrocellulose membranes. Immunoblotting for CT␣ was performed by incubation of the membranes with a polyclonal antibody against 45 amino acids of the C-terminal phosphorylation domain of CT␣ (provided by Prof. Martin Post, Hospital for Sick Children, Toronto, Canada) (40) . This antibody does not cross-react with CT␤ isoforms because of sequence divergence in the C-terminal phosphorylation domain (12, 13) . The secondary antibody was goat anti-rabbit IgG conjugated to horseradish peroxidase. Immunoreactive bands were analyzed by the chemiluminescence method according to the manufacturer's instructions (Amersham Pharmacia Biotech).
CT Assays-CT activity during the cell cycle progression was assayed in C3H10T1/2 fibroblast homogenates by measuring the incorporation of [
3 H]phosphocholine into CDP-[ 3 H]choline. The cells were washed three times with ice-cold PBS and scraped with a rubber policeman into homogenizing buffer consisting of: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM EDTA, 1 mM EGTA, 0.1 mM phenylmethylsulfonyl fluoride, 10 mM NaF, 100 M Na 3 VO 4 , and 100 g/ml each of leupeptin and aprotinin. Cells were sonicated for 25 s at 4°C and the sonicate was stored at Ϫ20°C or Ϫ70°C. The standard CT assay contained 25 g of cell protein mixed in a buffer with 57.8 mM Tris-HCl (pH 7.5), 40 mM NaCl, 1.78 mM EDTA, 8.9 mM magnesium acetate, 1.5 mM [
3 H]phosphocholine, 3 mM CTP, and 0.2 mM phosphatidylcholineoleate (1:1) vesicles in a final volume of 100 l. The incubations were for 15 min at 37°C and the reactions were stopped by transferring the tubes into an 80°C water bath for 2 min. Samples were centrifuged at 2000 rpm for 5 min in a bench-top centrifuge and an aliquot of supernatant was spotted on Silica Gel 60 thin-layer plates. Plates were developed in a solvent system of methanol, 0.6% NaCl and concentrated NH 4 OH (10: 10:0.9, v/v). CDP-[
3 H]choline formation was identified by co-migration with a standard, scraped from the plate, and quantified by liquid scintillation spectrometry.
[ 3 H]Choline Incorporation into PC and Measurement of PC MassCells grown in duplicate 100-mm dishes were labeled for 10 min at 37°C with 5 Ci/ml [methyl-
3 H]choline (Amersham Pharmacia Biotech). Incorporation of label was stopped by removing the medium, washing the cells three times with ice-cold buffer (50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1 mM EDTA), and rapidly freezing the cells at Ϫ20°C. Cells were harvested in PBS, pelleted by centrifugation, re-suspended in PBS, and sonicated. Lipids were extracted and PC purified by thinlayer chromatography on Silica Gel G-60 plates with chloroform/methanol/acetic acid/formic acid/water (70:30:12:4:1) as a developing solvent. PC was visualized by iodine vapor, scraped from the plate, and the radioactivity in PC was measured by liquid scintillation spectrometry. For PC mass determination, cells were cultured and harvested as described above, except the radioactivity was omitted. PC mass was determined by measuring the phosphorus content (41).
RESULTS

C3H10T1/2 Cell Synchronization in G 0 and Cell Cycle Assessment-Incubation at a low serum concentration (0.5% FBS)
for 48 h arrested C3H10T1/2 fibroblasts at the G 0 /G 1 stage of the cell cycle, which represented between 70 and 75% of the cells as determined by fluorescent-activated cell sorter analysis (Fig. 1) . The incorporation of [ 3 H]thymidine into DNA was negligible in the serum-starved cells (Fig. 2) . The addition of 10% FBS resulted in a wave of [ 3 H]thymidine incorporation beginning 12-14 h after addition of serum, peaking at 22 h, and declining thereafter.
Maximal Induction of CT␣ Transcription Occurs in S Phase-We tested the expression of CT␣ mRNA by RT-PCR analysis of total RNA isolated from cells at time 0 and at various times during the cell cycle. As shown in Fig. 3 , the level of mRNA was increased at 16 and 20 h post-addition of serum coincident with the peak of [ 3 H]thymidine incorporation into DNA. The levels of mRNA for cyclophilin remained constant during this time period. We next utilized CT␣ promoter-reporter assays to test if the increase in CT␣ mRNA during the cell cycle might be due to enhanced transcriptional activity of the CT␣ gene. The activity of different CT␣ promoter-luciferase constructs was tested after stable expression. C3H10T1/2 cells were shown previously to contain adequate levels of nuclear factors to support the activation of the CT␣ promoter-luciferase constructs (23) . As shown in Fig. 4 , for the Ϫ201/ϩ38 promoter, addition of 10% FBS to quiescent cells resulted in increased luciferase activity beginning at 10 -12 h post-serum stimulation, peaking at 20 -24 h and declining thereafter. This rise in reporter activity was coincident, within experimental error, with the increase in CT␣ mRNA at 16 -20 h (Fig. 3) .
Previously we established that the removal of sequences 5Ј to position Ϫ201 in the CT␣ promoter did not significantly alter luciferase expression (Ϫ201/ϩ38 versus Ϫ2086/ϩ38) (23). In the current experiments, deletion of 71 bp in the 3Ј direction (Ϫ201/ϩ38 versus Ϫ130/ϩ38) resulted in an average 45% reduction in reporter activity ( Fig. 5 compared with Fig. 4) . The time post-serum addition for the increase in Ϫ130/ϩ38-luciferase reporter activity was similar to CT␣ mRNA (Fig. 3) and the Ϫ201/ϩ38-luciferase reporter construct (Fig. 4) . A more truncated promoter (Ϫ52/ϩ38) did not show a change in luciferase activity during the cell cycle (Fig. 6 ). Also shown in Fig. 6 are the results from other cell lines that stably expressed one of the promoter constructs. From the results in Figs. 4 -6 , we established that the promoter regulatory elements between Ϫ52 and Ϫ130 are involved in positive regulation of CT␣ transcription during the late G 1 /S phase of the cell cycle.
Thus, we conclude that there is enhanced transcription of the CT␣ gene occurring during the S phase of the cell cycle in C3H10T1/2 murine fibroblasts. The promoter elements between Ϫ130 and Ϫ52 are required for this regulation.
Increased PC Synthesis and Total CT Activity during G 1 Phase of the Cell Cycle-The incorporation of [
3 H]choline into PC was stimulated 2-fold between 6 and 8 h after the addition of 10% FBS compared with that in quiescent cells in 0.5% FBS (Fig. 7A) . Incorporation of label increased until 16 -18 h at A cell line stably transfected with a CT␣ (Ϫ201/ϩ38) luciferase reporter construct was incubated in DMEM ϩ 0.5% FBS for 48 h followed by addition of FBS to a final concentration of 10%. Relative luciferase activity at various time points post-serum stimulation was calculated as a ratio of luciferase activity at a time point versus the luciferase activity at t ϭ 0 (quiescent cells, before serum addition). The results are the mean Ϯ S.E. for six to seven experiments.
which time there was a 4-fold increase compared with early time points. Subsequently, there was a decline in [ 3 H]choline incorporation to basal levels at 24 h after the addition of serum. The mass of PC also increased (Fig. 7B) .
CT activity (Fig. 8) was also enhanced more than 2-fold compared with quiescent cells (t ϭ 0) 6 h after the addition of serum. CT enzyme activity continued to rise gradually for an additional 16 h, at which time there was a 4-fold increase versus quiescent cells. By 24 h CT activity was still 2-fold higher than observed at time 0.
DISCUSSION
We report for the first time regulation of the transcriptional expression of an enzyme in mammalian phospholipid biosynthesis during the cell cycle. Intuitively one might have expected increased transcription would occur prior to enhanced PC biosynthesis that has been shown to be required for cell division (36) . Our studies clearly show this is not the case. Increased PC synthesis occurs during the G 1 phase of the cell cycle prior to enhanced transcription of the CT␣ gene that occurs during the S phase of the cell cycle. This result is in line with the long-held view that PC synthesis can be rapidly modulated by reversible binding of CT␣ to cellular membranes (1, 8, (42) (43) (44) without an increased amount of CT protein. Thus, cells can respond to a need for PC in seconds without the need for an increase in transcription/translation. Since PC is critical for cell survival (36, 45, 46 ) such a rapid mechanism for regulating PC synthesis might have had evolutionary value. The increase in CT␣ transcription during the S phase appears to be important for increasing the level of CT␣ in a cell in preparation for cell division.
Increased PC Biosynthesis during G 1 Phase of the Cell Cycle-The major increase in [ 3 H]choline incorporation into PC occurred during the G 1 phase of the cell cycle. This observation agrees with studies in a macrophage cell line that is dependent on colony stimulating factor (16, 35) . Our results with respect to mRNA measurements were different from those reported with the macrophage cell line (16) . We observed no increase in CT␣ mRNA until the S phase whereas a rapid increase in CT mRNA (CT␤ was not known in 1991) was reported in the macrophage cell line shortly after the addition of colony stimulating factor. This increase in mRNA was attributed to enhanced stability but CT transcription rates were not measured (16) . The subcellular location of CT␣ during the cell cycle was studied in IIC9 fibroblasts when serum was added to quiescent cells (47) . They found a redistribution of CT␣ from the nucleus to the endoplasmic reticulum early in G 1 that correlated with rapid synthesis of PC. In contrast, such a re-distribution was not observed in other cell lines with CT␣ tagged with green fluorescent protein (48) . All the studies agree that there is a stimulation of PC biosynthesis in the G 1 phase of the cell cycle.
Despite dozens of immunoblots with different antibodies to CT␣, we were not able to obtain sufficient specificity to have confidence in these experiments. Thus, although the same antibody had little to no cross-reactivity with homogenates of Chinese hamster ovary cells, we obtained ϳ10 immunoreacting bands in extracts from C3H10T1/2 fibroblasts. Thus, we could not measure the amount of CT␣ protein in these experiments nor could we study the state of phosphorylation.
Transcriptional Regulation of the CT␣ Gene during the Cell Cycle-The studies reported in this paper provide the basis for future investigations on identification of the trans-activating factors responsible for enhanced transcription of the CT␣ gene during the S phase of the cell cycle. The two obvious candidates are Sp1 and transcription enhancer factor 4, both of which have been shown to bind in the Ϫ130/Ϫ52 region of the CT␣ promoter (23, 27) .
The Ϫ90/Ϫ52 region of the CT␣ promoter contains a multiple binding site for Sp1 which enhanced luciferase expression (23) . Another Sp1 element (Ϫ144 to Ϫ136, antisense orientation) attenuated CT␣ promoter activity in both C3H10T1/2 and RH-7777 McArdle cells when transiently transfected with the Ϫ201/ϩ38 promoter construct (23) . In those studies, the deletion of 71 bp (Ϫ201/ϩ38 versus Ϫ130/ϩ38) resulted in a 2.5-3-fold enhanced expression of the reporter gene. Thus, the increased promoter activity observed in this study with the Ϫ201/ ϩ38 promoter construct (compared with the Ϫ130/ϩ38 construct) during the S phase of the cell cycle in the C3H10T1/2 cells was unexpected and the mechanism of activation is unclear. It is known that silencers can exert negative control on constitutive promoters in many genes but the exact mechanism is not well defined (49). It may be that these silencers are down-regulated during the cell cycle or inhibited during the S phase of the cell cycle. Alternatively, there may be differences in promoter activation in this region in stable (this study) versus transiently transfected cells (49). Moreover, when the Ϫ201/ϩ38 construct was co-transfected with a Sp1 expression construct (pPacSp1) into Sp1-deficient Drosophila Schneider 2 cells, a marked increase in luciferase activity was noted (Ϫ202/ ϩ38 versus Ϫ130/ϩ38) (26) . Clearly, there is much to be learned about the relationships among the various elements in the CT␣ promoter and the trans-acting factors.
In conclusion, increased transcription of the CT␣ gene occurs during the S phase of the cell cycle in C3H10T1/2 cells. This increase provides sufficient enzyme for PC biosynthesis in both daughter cells after mitosis.
